# Feminizing Hormone Therapy and the Rectal Mucosa Immune Environment in Transgender Women

> **NCT04531943** · — · COMPLETED · sponsor: **Emory University** · enrollment: 285 (actual)

## Conditions studied

- HIV Prevention

## Interventions

- **DRUG:** Estrogen
- **DRUG:** Estrogen plus Progesterone

## Key facts

- **NCT ID:** NCT04531943
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-01
- **Primary completion:** 2024-04-04
- **Final completion:** 2024-04-04
- **Target enrollment:** 285 (ACTUAL)
- **Last updated:** 2025-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04531943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04531943, "Feminizing Hormone Therapy and the Rectal Mucosa Immune Environment in Transgender Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04531943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*